APA (7th ed.) Citation

Hashemi, M., Zali, A., Golmakani, E., Delshad, M. H., Shadnoush, M., & Akbari, M. (2021). Efficacy, safety, and tolerability of sublingual fentanyl orally disintegrating tablet in the treatment of breakthrough cancer pain: A randomized, double-blind, placebo-controlled study. DARU: Journal of Pharmaceutical Sciences, 29, 51. https://doi.org/10.1007/s40199-020-00381-6

Chicago Style (17th ed.) Citation

Hashemi, Masoud, Alireza Zali, Ebrahim Golmakani, Mohammad Hossein Delshad, Mahdi Shadnoush, and Mohammad-Esmaeil Akbari. "Efficacy, Safety, and Tolerability of Sublingual Fentanyl Orally Disintegrating Tablet in the Treatment of Breakthrough Cancer Pain: A Randomized, Double-blind, Placebo-controlled Study." DARU: Journal of Pharmaceutical Sciences 29 (2021): 51. https://doi.org/10.1007/s40199-020-00381-6.

MLA (9th ed.) Citation

Hashemi, Masoud, et al. "Efficacy, Safety, and Tolerability of Sublingual Fentanyl Orally Disintegrating Tablet in the Treatment of Breakthrough Cancer Pain: A Randomized, Double-blind, Placebo-controlled Study." DARU: Journal of Pharmaceutical Sciences, vol. 29, 2021, p. 51, https://doi.org/10.1007/s40199-020-00381-6.